Supplementary Figure 12 from Early Changes in Tumor-Naive Cell-Free Methylomes and Fragmentomes Predict Outcomes in Pembrolizumab-Treated Solid Tumors

Eric Y. Stutheit-Zhao,Enrique Sanz-Garcia, Zhihui (Amy) Liu,Derek Wong,Kayla Marsh,Albiruni R. Abdul Razak,Anna Spreafico,Philippe L. Bedard,Aaron R. Hansen, Stephanie Lheureux,Dax Torti,Bernard Lam, Shih Yu Cindy Yang,Justin Burgener,Ping Luo,Yong Zeng,Nicholas Cheng,Philip Awadalla,Scott V. Bratman,Pamela S. Ohashi,Trevor J. Pugh,Lillian L. Siu

crossref（2024）

引用 0|浏览5

暂无评分

摘要

Multivariate Cox analysis of change in cancer mutation concentration (CMC) from baseline to cycle 3 of pembrolizumab. Covariates include cohort, PD-L1 expression, and tumor mutation burden

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要